Four IPOs are scheduled for the WEEK Ahead. Translation at the moment: No August Slow Down!
In a typical year, August would see a slow down in the syndicate market… But 2020 is not your typical year! 12 deals have come so far in August with an average opening of 50.2%!!! Four more deals are slated to come this week.
Debuting Wednesday (8/19)
Harmony Biosciences Holdings Inc (HRMY) — They are a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
Inhibrx, Inc. (INBX) — They are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform.
Debuting Friday (8/21)
Kymera Therapeutics (KYMR) — They are a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Nano-X Imaging Ltd. (NNOX) — They are focused on applying their proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe.
To find out more on the four deals this week, click here for more details!
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish